AAAAAA
Results: 26-50/77
Authors:
LEXA D
KEMATICK RJ
MYERS CE
Citation: D. Lexa et al., THERMODYNAMICS OF PHASE-FORMATION OF THE COBALT SILICIDES, Chemistry of materials, 8(11), 1996, pp. 2636-2642
Authors:
KEMATICK RJ
MYERS CE
Citation: Rj. Kematick et Ce. Myers, THERMODYNAMICS OF THE PHASE-FORMATION OF THE TITANIUM SILICIDES, Chemistry of materials, 8(1), 1996, pp. 287-291
Authors:
MYERS CE
GLUCK MA
Citation: Ce. Myers et Ma. Gluck, CORTICO-HIPPOCAMPAL REPRESENTATIONS IN SIMULTANEOUS ODOR DISCRIMINATION - A COMPUTATIONAL INTERPRETATION OF EICHENBAUM, MATHEWS, AND COHEN (1989), Behavioral neuroscience, 110(4), 1996, pp. 685-706
Authors:
BOWDEN CJ
FIGG WD
DAWSON NA
SARTOR O
BITTON RJ
WEINBERGER MS
HEADLEE D
REED E
MYERS CE
COOPER MR
Citation: Cj. Bowden et al., A PHASE I II STUDY OF CONTINUOUS-INFUSION SURAMIN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER - TOXICITY AND RESPONSE/, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 1-8
Authors:
DALKIN AC
GILRAIN JT
BRADSHAW D
MYERS CE
Citation: Ac. Dalkin et al., ACTIVIN INHIBITION OF PROSTATE-CANCER CELL-GROWTH - SELECTIVE ACTIONSON ANDROGEN-RESPONSIVE LNCAP CELLS, Endocrinology, 137(12), 1996, pp. 5230-5235
Authors:
MYERS CE
Citation: Ce. Myers, NEEDED - AN INTERDISCIPLINARY APPROACH TO DRUG MISADVENTURES, American journal of health-system pharmacy, 52(4), 1995, pp. 367-367
Authors:
MYERS CE
Citation: Ce. Myers, WHERE ARE ASHPS PRODUCTS AND SERVICES FOR TECHNICIANS, American journal of health-system pharmacy, 52(1), 1995, pp. 33
Authors:
GLUCK MA
MYERS CE
Citation: Ma. Gluck et Ce. Myers, REPRESENTATION AND ASSOCIATION IN MEMORY - A NEUROCOMPUTATIONAL VIEW OF HIPPOCAMPAL FUNCTION, Current directions in psychological science, 4(1), 1995, pp. 23-29
Authors:
MYERS CE
SHAH AH
KEMATICK RJ
Citation: Ce. Myers et al., THE VAPORIZATION BEHAVIOR AND THERMODYNAMIC STABILITY OF V12P7(S) ANDV4P3(S), Journal of alloys and compounds, 217(2), 1995, pp. 240-244
Authors:
MYERS CE
GLUCK MA
GRANGER R
Citation: Ce. Myers et al., DISSOCIATION OF HIPPOCAMPAL AND ENTORHINAL FUNCTION IN ASSOCIATIVE LEARNING - A COMPUTATIONAL APPROACH, Psychobiology, 23(2), 1995, pp. 116-138
Authors:
BITTON RJ
FIGG WD
VENZON DJ
DALAKAS MC
BOWDEN C
HEADLEE D
REED E
MYERS CE
COOPER MR
Citation: Rj. Bitton et al., PHARMACOLOGICAL VARIABLES ASSOCIATED WITH THE DEVELOPMENT OF NEUROLOGIC TOXICITY IN PATIENTS TREATED WITH SURAMIN, Journal of clinical oncology, 13(9), 1995, pp. 2223-2229
Authors:
PISCITELLI SC
THIBAULT A
FIGG WD
TOMPKINS A
HEADLEE D
LIEBERMANN R
SAMID D
MYERS CE
Citation: Sc. Piscitelli et al., DISPOSITION OF PHENYLBUTYRATE AND ITS METABOLITES, PHENYLACETATE AND PHENYLACETYLGLUTAMINE, Journal of clinical pharmacology, 35(4), 1995, pp. 368-373
Authors:
DANESI R
FIGG WD
REED E
MYERS CE
Citation: R. Danesi et al., PACLITAXEL (TAXOL) INHIBITS PROTEIN ISOPRENYLATION AND INDUCES APOPTOSIS IN PC-3 HUMAN PROSTATE-CANCER CELLS, Molecular pharmacology, 47(6), 1995, pp. 1106-1111
Authors:
BORNER MM
MYERS CE
SARTOR O
SEI Y
TOKO T
TREPEL JB
SCHNEIDER E
Citation: Mm. Borner et al., DRUG-INDUCED APOPTOSIS IS NOT NECESSARILY DEPENDENT ON MACROMOLECULAR-SYNTHESIS OR PROLIFERATION IN THE P53-NEGATIVE HUMAN PROSTATE-CANCER CELL-LINE PC-3, Cancer research, 55(10), 1995, pp. 2122-2128
Authors:
DAWSON NA
COOPER MR
FIGG WD
HEADLEE DJ
THIBAULT A
BERGAN RC
STEINBERG SM
SAUSVILLE EA
MYERS CE
SARTOR O
Citation: Na. Dawson et al., ANTITUMOR-ACTIVITY OF SURAMIN IN HORMONE-REFRACTORY PROSTATE-CANCER CONTROLLING FOR HYDROCORTISONE TREATMENT AND FLUTAMIDE WITHDRAWAL AS POTENTIALLY CONFOUNDING VARIABLES, Cancer, 76(3), 1995, pp. 453-462
Authors:
THIBAULT A
SAMID D
COOPER MR
FIGG WD
TOMPKINS AC
PATRONAS N
HEADLEE DJ
KOHLER DR
VENZON DJ
MYERS CE
Citation: A. Thibault et al., PHASE-I STUDY OF PHENYLACETATE ADMINISTERED TWICE-DAILY TO PATIENTS WITH CANCER, Cancer, 75(12), 1995, pp. 2932-2938
Authors:
HUDGINS WR
SHACK S
MYERS CE
SAMID D
Citation: Wr. Hudgins et al., CYTOSTATIC ACTIVITY OF PHENYLACETATE AND DERIVATIVES AGAINST TUMOR-CELLS - CORRELATION WITH LIPOPHILICITY AND INHIBITION OF PROTEIN PRENYLATION, Biochemical pharmacology, 50(8), 1995, pp. 1273-1279
Authors:
DANESI R
MCLELLAN CA
MYERS CE
Citation: R. Danesi et al., SPECIFIC LABELING OF ISOPRENYLATED PROTEINS - APPLICATION TO STUDY INHIBITORS OF THE POSTTRANSLATIONAL FARNESYLATION AND GERANYLGERANYLATION, Biochemical and biophysical research communications, 206(2), 1995, pp. 637-643
Authors:
FIGG WD
SARTOR O
COOPER MR
THIBAULT A
BERGAN RC
DAWSON N
REED E
MYERS CE
Citation: Wd. Figg et al., PROSTATE-SPECIFIC ANTIGEN DECLINE FOLLOWING THE DISCONTINUATION OF FLUTAMIDE IN PATIENTS WITH STAGE D2 PROSTATE-CANCER, The American journal of medicine, 98(4), 1995, pp. 412-414
Authors:
SARTOR O
COOPER M
WEINBERGER M
HEADLEE D
THIBAULT A
TOMPKINS A
STEINBERG S
FIGG WD
LINEHAN WM
MYERS CE
Citation: O. Sartor et al., SURPRISING ACTIVITY OF FLUTAMIDE WITHDRAWAL, WHEN COMBINED WITH AMINOGLUTETHIMIDE, IN TREATMENT OF HORMONE-REFRACTORY PROSTATE-CANCER, Journal of the National Cancer Institute, 86(3), 1994, pp. 222-227
Authors:
LAROCCA RV
COOPER MR
DANESI R
STEIN CA
MYERS CE
Citation: Rv. Larocca et al., SURAMIN THERAPY FOR MALIGNANT THYMOMA - A CASE-REPORT, European journal of cancer, 30A(5), 1994, pp. 718-719
Authors:
FIGG WD
WALLS RG
COOPER MR
THIBAULT A
SARTOR O
MCCALL NA
MYERS CE
SAMID D
Citation: Wd. Figg et al., IN-VITRO ANTITUMOR EFFECT OF HYDROXYUREA ON HORMONE-REFRACTORY PROSTATE-CANCER CELLS AND ITS POTENTIATION BY PHENYLBUTYRATE, Anti-cancer drugs, 5(3), 1994, pp. 336-342
Authors:
YAMAZAKI H
SCHNEIDER E
MYERS CE
SINHA BK
Citation: H. Yamazaki et al., ONCOGENE OVEREXPRESSION AND DE-NOVO DRUG-RESISTANCE IN HUMAN PROSTATE-CANCER CELLS, Biochimica et biophysica acta. Molecular basis of disease, 1226(1), 1994, pp. 89-96
Authors:
BENCHEKROUN MN
MYERS CE
SINHA BK
Citation: Mn. Benchekroun et al., FREE-RADICAL FORMATION BY ANSAMYCIN BENZOQUINONE IN HUMAN BREAST-TUMOR CELLS - IMPLICATIONS FOR CYTOTOXICITY AND RESISTANCE, Free radical biology & medicine, 17(3), 1994, pp. 191-200
Authors:
SCHLAIFER D
COOPER MR
ATTAL M
ROUSSEAU A
PRIS J
LAURENT G
MYERS CE
Citation: D. Schlaifer et al., POTENTIAL STRATEGIES FOR CIRCUMVENTING MYELOPEROXIDASE-CATALYZED DEGRADATION OF VINCA ALKALOIDS, Leukemia, 8(4), 1994, pp. 668-671